The druggable genome and support for target identification and validation in drug development.

Abstract excerpt

Target identification (determining the correct drug targets for a disease) and target validation (demonstrating an effect of target perturbation on disease biomarkers and disease end points) are important steps in drug development. Clinically relevant associations of variants in genes encoding drug targets model the effect of modifying the same targets pharmacologically. To delineate drug development (including...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Discovery
• Share to Drug Repositioning